Biomarkers Overview
JH · Effective Oct 1, 2015
30 active Medicare policies list 0388U, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Jul 17, 2023
JH · Effective Jul 17, 2023
JL · Effective Jul 17, 2023
J15 · Effective May 13, 2019
JE · Effective Jun 3, 2019
JF · Effective Jun 3, 2019
JJ · Effective Apr 8, 2019
4 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 0388U |
|---|---|---|
| Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance | Aug 22, 2026 | Covered |
| Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance | Jun 14, 2026 | Covered |
| Policy | Effective | Status of 0388U |
|---|---|---|
| Concert Genetic Testing Oncology: Solid Tumor Molecular Diagnostics |
JM · Effective Apr 8, 2019
J5 · Effective Apr 15, 2019
J8 · Effective Apr 15, 2019
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
J9 · Effective Oct 1, 2015
J5 · Effective Jul 1, 2023
National · Effective Jul 1, 2023
National · Effective Jun 19, 2025
National · Effective Jan 22, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
JL · Effective Jul 1, 2026
J9 · Effective Jul 1, 2026
| Not recorded |
| Referenced |
| Policy | Effective | Status of 0388U |
|---|---|---|
| Circulating Tumor DNA and Circulating Tumor Cells for Management (Liquid Biopsy) of Solid Tumor Cancers | Jul 1, 2026 | Covered |